Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Biodegradable Injectable Material Saves Wounded Soldiers

By HospiMedica International staff writers
Posted on 08 Dec 2014
An injectable coagulation gel could buy wounded soldiers the time they need to survive by preventing blood loss from serious internal injuries.

Developed by researchers at Texas A&M University (TAMU; College Station, TX, USA), Harvard University (Boston, MA, USA), and the Massachusetts Institute of Technology (MIT; Cambridge, MA, USA), the potentially life-saving treatment comes in the form of a biodegradable gelatin hydrogel substance embedded with nano-sized silicate discs that aid in coagulation. Once injected, the material solidifies at the targeted area, promoting coagulation.

The two-dimensional, disc-shaped synthetic silicate nanoplatelets have a structure, composition, and arrangement that result in both positive and negative charges on each particle. These charges cause the platelets to modify the hydrogel so that it temporarily changes its viscosity when mechanical force is applied, like ketchup being squeezed from a bottle. This allows the hydrogel to be injected and regain its shape once inside the body. In addition to changing the mechanical properties of the hydrogel, the disc-shaped nanoplatelets also interact with blood to promote clotting in as little as one minute.

The silicate nanoplatelets were demonstrated to decrease in vitro blood clotting times by 77%, and to form stable clot-gel systems. In vivo tests indicated that the nanocomposites are biocompatible and capable of promoting hemostasis in an otherwise lethal liver laceration. According to the researchers, the combination of injectability, rapid mechanical recovery, physiological stability, and the ability to promote coagulation result in a hemostat for treating incompressible wounds in out-of-hospital emergency conditions. The study was published in the October 2014 issue of ACS Nano.

“Most of these penetrating injuries, which today are the result of explosive devices, rupture blood vessels and create internal hemorrhages through which a person is constantly losing blood,” said lead author assistant professor of biomedical engineering Akhilesh Gaharwar, PhD. “You can’t apply pressure inside your body, so you have to have something that can quickly clot the blood without needing pressure.”

Two-dimensional materials are ultrathin substances with high surface area, but a thickness of just a few nanometers or less. For example, if a sheet of paper is 100,000 nanometers thick, the silicate nanoplatelets are just one nanometer thick.

Related Links:

Texas A&M University
Harvard University
Massachusetts Institute of Technology (MIT)



Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Transportation Stretcher
ES709
New
Imaging Table
CFPM200
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Trilogy Valve with locator technology is the only TAVI system approved for aortic regurgitation (Photo courtesy of JenaValve)

New Transcatheter Valve Found Safe and Effective for Treating Aortic Regurgitation

Aortic regurgitation is a condition in which the aortic valve does not close properly, allowing blood to flow backward into the left ventricle. This results in decreased blood flow from the heart to the... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.